FBRX

NASDAQStock

Forte Biosciences, Inc.

$26.56-0.56 (-2.06%)

52-Week Range

$5.25

$35.53

Key Stats

Market Cap

332.7M

P/E Ratio

—

Dividend Yield

—

Beta

3.21

Volume

93.6K

Avg Volume

211.5K

Performance

-15.54%

+23.50%

+119.95%

YTD

+14.87%

+391.30%

+9.94%

-96.10%

Price Chart

ETF Exposure

FBRX is held by 11 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ATFV	Alger 35 ETF	1.20%	63,414	$129.6M	$108.0M	0.55%
SBIO	ALPS Medical Breakthroughs ETF	0.23%	11,166	$303K	$133.4M	0.50%
IWC	iShares Micro-Cap ETF	0.06%	28,126	$770K	$1.27B	0.60%
AVSC	Avantis U.S. Small Cap Equity ETF	0.01%	12,699	$344K	$2.36B	0.25%
VXF	Vanguard Extended Market ETF	0.00%	118,961	$3.5M	$84.10B	0.05%
VTI	Vanguard Total Stock Market ETF	0.00%	393,727	$11.5M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	2,070	$82K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	178	$7K	$1.29B	0.17%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	19	$768	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	691	$27K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	3	$132	$337.7M	0.32%

About FBRX ETF Exposure

Forte Biosciences, Inc. (FBRX) is held by 11 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 332.7M, FBRX is a widely held institutional stock. The stock currently trades at $26.56. Investors can gain exposure to FBRX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold FBRX, sorted by portfolio weight.